Home/Filings/4/0001209191-21-009038
4//SEC Filing

George Dan 4

Accession 0001209191-21-009038

CIK 0001652724other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 7:49 PM ET

Size

10.7 KB

Accession

0001209191-21-009038

Insider Transaction Report

Form 4
Period: 2021-02-09
George Dan
CFO and Treasurer
Transactions
  • Conversion

    Series B Preferred Stock

    2021-02-0910,7250 total
    Common Stock (10,725 underlying)
  • Conversion

    Series C Preferred Stock

    2021-02-0913,2880 total
    Common Stock (13,288 underlying)
  • Conversion

    Common Stock

    2021-02-09+10,72515,365 total
  • Conversion

    Common Stock

    2021-02-09+13,28828,653 total
Footnotes (1)
  • [F1]Each share of Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date.

Issuer

Lucira Health, Inc.

CIK 0001652724

Entity typeother

Related Parties

1
  • filerCIK 0001840534

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 7:49 PM ET
Size
10.7 KB